Double-blind, Phase2 Study of TS-071 in Patients With Type 2 Diabetes Mellitus (Confirmatory Study of Dose-Response)
Phase 2
- Conditions
- Type 2 Diabetes Mellitus
- Registration Number
- JPRN-jRCT2080221156
- Lead Sponsor
- Taisho Pharmaceutical co., LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 275
Inclusion Criteria
Type 2 diabetes mellitus
- HbA1c 6.5% to 10.0%
etc.
Exclusion Criteria
- Insulin-dependent (Require insulin regularly)
- Non-type 2 diabetes mellitus
- Having critical heart disease, other ciruculatory disease, cerebrovascular disorder, pancreatic disease and hematologic disease
etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c
- Secondary Outcome Measures
Name Time Method Blood-sugar level, etc.